We spoke to Dr Andrea Natale (Texas Cardiac Arrhythmia Institute, Austin, TX, USA) about the management of anticoagulation after atrial fibrillation ablation.
- What are the limitations of current recommendations for anticoagulation after atrial fibrillation (AF) ablation? (0.13)
- What factors should influence the decision to discontinue anticoagulation following AF ablation? (3.07)
Speaker disclosures: Dr Andrea Natale has nothing to declare in relation to this video interview.
Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Dr Andrea Natale as a highlight of the AF Symposium, January 2021.
Share this Video
Related Videos In Atrial Fibrillation
ESC Congress 2023 Amsterdam: David Conen, COP-AF trial
The COP-AF trial looked at the use of anti-inflammatory colchicine in patients undergoing major noncardiac thoracic surgery and reducing risk of cardiovascular complications, especially perioperative atrial fibrillation and myocardial injury after noncardiac surgery (MINS). We spoke to Prof. David Conen (Population Health Research Institute, Hamilton, ON, Canada), principle investigator of COP-AF and presenter at the […]
World Heart Rhythm Week: Considerations and challenges in arrhythmia
It’s World Heart Rhythm Week 2023! Learn about key considerations for managing and treating arrhythmias, ongoing research and the importance of seeking medical advice for syncope.
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]